AUROBINDO PHARMA LTD FDA Approval ANDA 212289

ANDA 212289

AUROBINDO PHARMA LTD

FDA Drug Application

Application #212289

Application Sponsors

ANDA 212289AUROBINDO PHARMA LTD

Marketing Status

Prescription001

Application Products

001SPRAY, METERED;NASALEQ 0.125MG BASE/SPRAY0AZELASTINE HYDROCHLORIDEAZELASTINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2020-05-08STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

AUROBINDO PHARMA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212289
            [companyName] => AUROBINDO PHARMA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"AZELASTINE HYDROCHLORIDE","activeIngredients":"AZELASTINE HYDROCHLORIDE","strength":"EQ 0.125MG BASE\/SPRAY","dosageForm":"SPRAY, METERED;NASAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/08\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-05-08
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.